Schulz HU - Search Results

1

[The solubility and bioequivalence of silymarin preparations].

Schulz HU, Schürer M, Krumbiegel G, Wächter W, Weyhenmeyer R, Seidel G. Schulz HU, et al. Arzneimittelforschung. 1995 Jan;45(1):61-4. Arzneimittelforschung. 1995. PMID: 7893272 Clinical Trial. German.

2

Simultaneous determination of spirapril and spiraprilat in plasma by capillary gas chromatography-mass spectrometry.

Schürer M, Amschler S, Schulz HU, Schäfer HF. Schürer M, et al. Among authors: schulz hu. Arzneimittelforschung. 2003;53(5):307-13. doi: 10.1055/s-0031-1297114. Arzneimittelforschung. 2003. PMID: 12854357

3

Drug interaction of spirapril hydrochloride monohydrate and hydrochlorothiazide. A clinical study to compare the pharmacokinetics after administration of spirapril hydrochloride monohydrate tablets, hydrochlorothiazide tablets and fixed combination bi-layer tablets.

Schürer M, Erb K, Junge K, Schäfer HF, Schulz HU, Amschler S, Krupp S, Hermann R. Schürer M, et al. Among authors: schulz hu. Arzneimittelforschung. 2003;53(6):414-9. doi: 10.1055/s-0031-1297129. Arzneimittelforschung. 2003. PMID: 12872612 Clinical Trial.

4

Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.

Schulz HU, Schürer M, Bässler D, Weiser D. Schulz HU, et al. Arzneimittelforschung. 2005;55(1):15-22. doi: 10.1055/s-0031-1296820. Arzneimittelforschung. 2005. PMID: 15727160 Clinical Trial.

5

Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.

Schulz HU, Schürer M, Bässler D, Weiser D. Schulz HU, et al. Arzneimittelforschung. 2005;55(10):561-8. doi: 10.1055/s-0031-1296905. Arzneimittelforschung. 2005. PMID: 16294501 Clinical Trial.

6

Investigation of the effect on photosensitivity following multiple oral dosing of two different hypericum extracts in healthy men.

Schulz HU, Schürer M, Bässler D, Weiser D. Schulz HU, et al. Arzneimittelforschung. 2006;56(3):212-21. doi: 10.1055/s-0031-1296713. Arzneimittelforschung. 2006. PMID: 16618014 Clinical Trial.

7

Lack of influence of glycine on the single dose pharmacokinetics of acetylsalicylic acid in man.

Schurer M, Bias-Imhoff U, Schulz HU, Schwantes U, Riechers AM. Schurer M, et al. Among authors: schulz hu. Int J Clin Pharmacol Ther. 1996 Jul;34(7):282-7. Int J Clin Pharmacol Ther. 1996. PMID: 8832303 Clinical Trial.

8

Pharmacokinetic properties of tramadol sustained release capsules. 1st communication: investigation of dose linearity.

Schulz HU, Raber M, Schürer M, Amschler S, Momberger H. Schulz HU, et al. Arzneimittelforschung. 1999 Jul;49(7):582-7. doi: 10.1055/s-0031-1300466. Arzneimittelforschung. 1999. PMID: 10442205 Clinical Trial.

9

[The plasma level of the neurotoxin 1-trichloromethyl-1,2,4,5-tetrahydro-beta-carboline (TaClo) in man after oral administration of chloral hydrate].

Leuschner J, Beuscher N, Zimmermann T, Schürer M, Schulz HU, Jeromin J, Ritter H. Leuschner J, et al. Among authors: schulz hu. Arzneimittelforschung. 1998 Jan;48(1):1-5. Arzneimittelforschung. 1998. PMID: 9522023 Clinical Trial. German.

10

Pharmacokinetic properties of tramadol sustained release capsules. 2nd communication: investigation of relative bioavailability and food interaction.

Raber M, Schulz HU, Schürer M, Bias-Imhoff U, Momberger H. Raber M, et al. Among authors: schulz hu. Arzneimittelforschung. 1999 Jul;49(7):588-93. doi: 10.1055/s-0031-1300467. Arzneimittelforschung. 1999. PMID: 10442206 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page